RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 365-371

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis

By Zhou Guo-Wu  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 529-535

Springer Publishing Company

Access to resources Recommend Favorite

RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects

By Wang Zhanwei   Dong Hairong   Fu Yuanyuan   Ding Haixia  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 765-769

Springer Publishing Company

Access to resources Recommend Favorite

TNFα −308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls

By Fang Fang  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 267-271

Springer Publishing Company

Access to resources Recommend Favorite

TGF-1 29T/C polymorphism and breast cancer risk: a meta-analysis involving 25,996 subjects

By Huang Yongsheng  

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 863-868

Springer Publishing Company

Access to resources Recommend Favorite